How the East Was Won: Transnational Social Forces and the Neoliberalisation of Poland's Post-Communist Transition*

The article proposes a Gramscian account of Poland's transition to a market economy. It considers what has generated, sustained, and legitimated neoliberal hegemony and illustrates how neoliberal ideas attained a hegemonic position through the development of a particular class and national state project. It uncovers where the agents of this process are visible by contrasting two waves of post-communist reform that have contributed to the reconfiguration of the Polish political economy in the current conjuncture of global restructuring. Firstly, it focuses on the centrepiece of neoliberal efforts to constitute hegemony in the shape of the “shock therapy” reform programme and then on the later application of a highly selective form of Europeanisation. Finally the article considers which social forces have offered the most effective resistance to neoliberalism in an appraisal of the recent populist turn in Polish politics.     

Does the amount of participation matter? Public comments,agency responses and the time to finalize a regulation

The notice and comment rulemaking process is a fundamental part of how agencies write regulations. While this process is starting to receive more empirical attention, the question of how the number of comments that an agency receives affects its decision-making process has received little examination. This paper uses Boolean analysis to examine nine rules from two agencies at the Department of Health and Human Services and evaluates the impact of a high volume of comments on agency changes to proposed rules and the time an agency takes to finalize a proposed rule. These nine cases suggest that agencies are most likely to change their proposals when they receive a high volume of comments on highly complex rules that are not very politically salient. Highly complex rules are also likely to take a long time to finalize when there are many public comments however it is often other factors that cause a long delay between proposed and final rules.

Managing generic competition and patent strategies in the pharmaceutical industry

Legal context: The income streams of originating pharmaceutical manufacturersare under pressure as never before, from increasing R&Dcosts, regulatory pressures, and competition from generic manufacturers.This article examines the various strategies which originatingpharmaceutical manufacturers have adopted in response to thesethreats. Key points: The authors consider various strategies, including SupplementaryProtection Certificates, life-cycle management (‘evergreening’),second pharmaceutical use claims, trade marks, and the use ofdata exclusivity and interim injunctions, in order to prolongthe protection given to existing products, and to manage competitionfrom generic manufacturers. Practical significance: The authors also include two real-life case studies in orderto illustrate the practical applications of the strategies discussedin the article.     

Correction to: Mass Media and Electoral Preferences During the 2016 US Presidential Race

Political Behavior - This erratum provides additional analysis and clarification relating to the original version of the article.